Delivery Order SPE2DB22D2206-SPE2DB25FHV53
Award Date 7/10/25
Potential Completion Date 7/31/25
Potential Value $31K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $18,566.92 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mekinist 2 mg tablets (30-count units) under a firm fixed-price contract valued at $19,341.02. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy used primarily for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Mekinist 2 mg tablets (30-count units) valued at $9,670.51 with a firm fixed price structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, reflecting the company's role in...
- The Defense Logistics Agency awarded a $40,764.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 25, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where the contractor maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,670.51 on September 9, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $9,670.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This contract represents a non-set-aside, competitively awarded delivery order executed by the prime contractor's Corporate Office, located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,588.64 to AmerisourceBergen Drug Corp for supply of Mekinist 2 mg tablets (30-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy used in melanoma and other oncological treatments, reflecting the...
- The Defense Logistics Agency awarded a $17,104.98 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 25, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical supply needs,...
- The Defense Logistics Agency awarded a $8.55K delivery order to AmerisourceBergen Drug Corp for Mekinist 0.5 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside competitive award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, reflecting the breadth of pharmaceutical products procured...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) under a competitive procurement with no set-aside designation. The contract, valued at $19,341.02, is scheduled for completion by July 11, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's broader...